Publication | Open Access
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis
215
Citations
26
References
2010
Year
This study provides Class III evidence that add-on rituximab reduces gadolinium-enhancing brain lesions in multiple sclerosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1